✦ LIBER ✦

Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib

✍ Scribed by Ruitong Xu; Hua Shen; Renhua Guo; Jing Sun; Wen Gao; Yongqian Shu

Book ID: 119196190
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 717 KB
Volume: 66
Category: Article
ISSN: 0753-3322
DOI: 10.1016/j.biopha.2012.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic inhibitory effects by the co

Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo

✍ Hang Zhu; Hua Cheng; Yuan Ren; Zhan Guo Liu; Yi Fang Zhang; Bing De Luo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 455 KB

Combined inhibition of IGFR enhances the

Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors

✍ Yun Jung Choi; Jin Kyung Rho; Byung-suk Jeon; Su Jin Choi; Su Cheol Park; Seung 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 544 KB

Combinatorial treatment of non-small-cel

Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy

✍ Luni Emdad; Irina V. Lebedeva; Zao-Zhong Su; Pankaj Gupta; Devanand Sarkar; Jeff 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

## Abstract Activation of the epidermal growth factor receptor (EGFR) contributes to the pathogenesis of non‐small‐cell lung carcinomas (NSCLC) and gefitinib, a selective reversible EGFR inhibitor, is effective in treating patients with NSCLC. However, clinical resistance to gefitinib is a frequent

Effects of Src inhibitors on cell growth

Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification

✍ Takeshi Yoshida; Isamu Okamoto; Wataru Okamoto; Erina Hatashita; Yuki Yamada; Ki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

207 POSTER Phase II study of gefitinib i

207 POSTER Phase II study of gefitinib in combination with cisplatin and concurrent radiotherapy in patients with stage III/IV squamous cell head and neck cancer and to analyse the effect of gefitinib on tumour gene expression

✍ E.H. Tan; C. Goh; A. Loy; S.S. Leong; W.T. Lim; C.K. Toh; T. Tan; J. Wee; K.W. F 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB